Licensing Opportunity For Pharmaceutical Companies
Med Services Europe GmbH has announced that it has obtained rights to out-license a portfolio of prescription pharmaceuticals.
Zurich, Switzerland(PRWEB) September 6, 2005 -- Med Services Europe GmbH, a
“Virtual European Headquarters” for Pharmaceutical and Medical Manufacturers,
has announced that it has obtained rights to out-license a portfolio of
prescription pharmaceuticals. (www.MedServicesEurope.com)
Dr. Gene Emmer, President of
Med Services Europe explained: “We have signed an agreement with a
European-based pharmaceutical company that grants us the right to develop a
network of distributors for an exciting portfolio of prescription pharmaceutical
products. Our client will launch the portfolio in their home market. Med
Services Europe will build and manage a network of pharmaceutical companies
which will be responsible for marketing, sales and distribution of these
products in their home markets. The products in the portfolio offer physicians
options for handling Hormone Replacement Therapy (HRT).”
Dr. Emmer
explained further about the opportunity that this portfolio presents to
pharmaceutical companies “The media has sensationalized the recent findings of
the Women’s Health Initiative (WHI) and there has been a strong over-reaction to
the study’s findings. This has caused many competitors to abandon this market.
However, most physicians agree that HRT is the only effective therapy for
climacteric symptoms of menopause, commonly known as hot-flashes, or hot-flush,
which can be extremely disabling for a large population of women. The market for
HRT products is very large and growing due to ageing of the population and it is
hungry for new launches. This portfolio offers many interesting advantages for
the market and for the pharmaceutical companies that will represent
them”
Dr Emmer encourages pharmaceutical companies to learn more about
the opportunity to in-license this portfolio of products. “This is a unique
opportunity to obtain marketing rights to an exciting portfolio of products,
which are effective for a large and growing market. The media attention to WHI
has served to decrease the competitive noise in this market and make this an
exciting time for companies coming with a new message.”
Pharmaceutical
companies interested in obtaining more information may contact Dr Emmer at Med
Services Europe in Switzerland.
About Med Services Europe:
Med
Services Europe GmbH is located in Zürich Switzerland and specializes in Sales,
Marketing and Business Development for Pharmaceutical and Medical manufacturers.
Med Services acts as a virtual European Headquarters by developing and managing
distribution networks for its clients. For more
information: www.MedServicesEurope.com or +41764249963.
# # #
Source : http://www.prweb.com/releases/2005/9/prweb279367.htm